Abstract Aims Neuropeptide Y (NPY) is the most abundant neuropeptide found in the heart
and is released alongside norepinephrine following prolonged sympathetic activation, a …

Plasma neuropeptide Y (NPY) was measured by radioimmunoassay in 43 patients with
congestive heart failure (CHF) and 20 healthy control subjects. The results showed that …

Background: Neuropeptide Y (NPY) is a multifaceted sympathetic neurotransmitter
regulating reflex cardiovascular control, myocardial cell growth, inflammation and innate …

Objective Neuropeptide Y (NPY) is released during sympathetic stimulation and mediates
the central effects of the adipostatic hormone leptin. The plasma concentration of NPY and …

Importance Chronic heart failure (CHF) is associated with increased sympathetic drive and
may increase expression of the cotransmitter neuropeptide Y (NPY) within sympathetic …

Background Chronic heart failure is associated with increased sympathetic nerve activity
and elevated plasma neuropeptide Y levels. The aim of this study was to investigate whether …

Chronic renal insufficiency is a situation characterized by high plasma concentration of
neuropeptide Y (NPY). Because this neuropeptide interferes with cardiovascular (CV) …

Study objective–The aim of the study was to measure plasma neuropeptide Y, which is
related to sympathetic nerve stimulation, in patients admitted to a coronary care unit and to …

Publisher Summary This chapter focuses on the attempts to further characterize the
relationship of NPY to NE release under physiological and pathophysiological conditions …

Abstract purpose: Our objectives were to assess whether plasma neuropeptide Y (NPY)
levels are elevated in patients with congestive heart failure (CHF) and whether or not NPY …